Gilead Sciences

@GileadSciences · Foster City, California · joined 02 Jun 2011

At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. Read more: https://t.co/TZWHS6iRTe

72 326Followers

198Following

4 667Posts total

14.6KViews on collected posts

Neueste Beiträge

Gilead Sciences@GileadSciences28 Aug

We’re honored to receive the 2026 ACS Heroes of Chemistry Award at #ACSFall2026 – reflecting years of antiviral chemistry and our commitment to advancing science that benefits patients. Learn more about our R&D approach: https://t.co/TsWS7CTMgR https://t.co/siofZziIDM 1.6K views · 5 likes · 1 reposts · 1 replies Open on X →

Gilead Sciences@GileadSciences27 Aug

#GileadNews: The U.S. FDA approves first and only single-tablet regimen for the treatment of HIV in adults who are virologically suppressed, including those on complex multi-tablet regimens. Learn more: https://t.co/ZzAqXVm6Qe https://t.co/YvFPdwpYIz 5.3K views · 26 likes · 7 reposts · 2 replies Open on X →

Gilead Sciences@GileadSciences24 Aug

#GileadNews: The European Commission (EC) expands role of our treatment for first-line metastatic triple-negative breast cancer (mTNBC), establishing it as the first and only antibody-drug conjugate for first-line treatment across PD-(L)1 status. https://t.co/qf94xxeTbG https://t 1.6K views · 5 likes · 2 reposts · 0 replies Open on X →

Gilead Sciences@GileadSciences4 Aug

#GileadNews: Today, Gilead announced second quarter 2026 results, including 10% year-over-year growth in our base business. Read more, including important cautionary statements about forward-looking information, here: https://t.co/m0775laYO1 https://t.co/pycs49jUIT 2.6K views · 6 likes · 1 reposts · 3 replies Open on X →

Gilead Sciences@GileadSciences2 Aug

@GileadSciences Monsters https://t.co/ZxQs3lHCdR 31 views · 1 likes · 0 reposts · 0 replies Open on X →

Gilead Sciences@GileadSciences1 Aug

@GileadSciences #quebradepatentesja 37 views · 1 likes · 0 reposts · 0 replies Open on X →

Gilead Sciences@GileadSciences24 Jul

#GileadNews: We received a #CHMP positive opinion for our combination regimen in PD-(L)1-positive first-line metastatic triple-negative breast cancer. If approved, patients with PD-(L)1 positive mTNBC will have a new treatment option in Europe. https://t.co/RYU4enosT1 https://t.c 3.5K views · 14 likes · 3 reposts · 5 replies Open on X →

Im Vergleich zu Konten gleicher Größe

6 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. liegt bei Reichweite und Interaktion unter vergleichbaren Konten.

Medianaufrufe1 611dieses Konto924Median für 10K–100K

Reichweite, %2.23%dieses Konto3.62%Median für 10K–100K

Interaktion, %0.58%dieses Konto1.52%Median für 10K–100K

Kennzahl	Dieses Konto	Median für 10K–100K	Verhältnis
Medianaufrufe pro Beitrag	1 611	924	1.74×
Reichweite (Aufrufe ÷ Follower)	2.23%	3.62%	0.62×
Interaktionsrate	0.58%	1.52%	0.38×

Weitere Konten dieser Größe → Mit einem anderen Konto vergleichen → Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.5K24 Jul

371 Aug

312 Aug

2.6K4 Aug

1.6K24 Aug

5.3K27 Aug

1.6K28 Aug

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.64%24 Jul

2.70%1 Aug

3.23%2 Aug

0.39%4 Aug

0.43%24 Aug

0.71%27 Aug

0.44%28 Aug

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes65.2%58 in total

Reposts15.7%14 in total

Replies12.4%11 in total

Quotes3.4%3 in total

Bookmarks3.4%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.